Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Development of a selective androgen receptor modulator for transdermal use in hypogonadal patients.

Krishnan V, Patel NJ, Mackrell JG, Sweetana SA, Bullock H, Ma YL, Waterhouse TH, Yaden BC, Henck J, Zeng QQ, Gavardinas K, Jadhav P, Saeed A, Garcia-Losada P, Robins DA, Benson CT.

Andrology. 2018 May;6(3):455-464. doi: 10.1111/andr.12479. Epub 2018 Mar 12.

2.

Molecular targets of androgen signaling that characterize skeletal muscle recovery and regeneration.

MacKrell JG, Yaden BC, Bullock H, Chen K, Shetler P, Bryant HU, Krishnan V.

Nucl Recept Signal. 2015 Oct 7;13:e005. doi: 10.1621/nrs.13005. eCollection 2015.

3.

Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice.

Yaden BC, Wang YX, Wilson JM, Culver AE, Milner A, Datta-Mannan A, Shetler P, Croy JE, Dai G, Krishnan V.

Am J Pathol. 2014 Apr;184(4):1152-66. doi: 10.1016/j.ajpath.2013.12.029.

PMID:
24655377
4.

Follistatin: a novel therapeutic for the improvement of muscle regeneration.

Yaden BC, Croy JE, Wang Y, Wilson JM, Datta-Mannan A, Shetler P, Milner A, Bryant HU, Andrews J, Dai G, Krishnan V.

J Pharmacol Exp Ther. 2014 May;349(2):355-71. doi: 10.1124/jpet.113.211169. Epub 2014 Mar 13.

PMID:
24627466
5.

Macrofinancing efficient remodeling of damaged muscle tissue.

Krishnan V, Yaden BC.

Cell Metab. 2013 Aug 6;18(2):149-51. doi: 10.1016/j.cmet.2013.07.011.

6.

Involvement of estrogen receptor β in maintenance of serotonergic neurons of the dorsal raphe.

Suzuki H, Barros RP, Sugiyama N, Krishnan V, Yaden BC, Kim HJ, Warner M, Gustafsson JÅ.

Mol Psychiatry. 2013 Jun;18(6):674-80. doi: 10.1038/mp.2012.62. Epub 2012 Jun 5.

PMID:
22665260
7.

Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand.

Tan XJ, Dai YB, Wu WF, Kim HJ, Barros RP, Richardson TI, Yaden BC, Warner M, McKinzie DL, Krishnan V, Gustafsson JÅ.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1708-12. doi: 10.1073/pnas.1121162109. Epub 2012 Jan 17.

8.

Two promoters mediate transcription from the human LHX3 gene: involvement of nuclear factor I and specificity protein 1.

Yaden BC, Garcia M 3rd, Smith TP, Rhodes SJ.

Endocrinology. 2006 Jan;147(1):324-37. Epub 2005 Sep 22.

PMID:
16179410
9.

DNA recognition properties of the LHX3b LIM homeodomain transcription factor.

Yaden BC, Savage JJ, Hunter CS, Rhodes SJ.

Mol Biol Rep. 2005 Mar;32(1):1-6.

PMID:
15865204
10.

The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand.

Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, Cheng CC, Zink RW, Barr RJ, Hepler CD, Krishnan V, Bullock HA, Burris LL, Galvin RJ, Bramlett K, Stayrook KR.

Mol Pharmacol. 2005 Mar;67(3):948-54. Epub 2004 Dec 15.

PMID:
15602004
11.

The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonist.

Krishnan V, Bullock HA, Yaden BC, Liu M, Barr RJ, Montrose-Rafizadeh C, Chen K, Dodge JA, Bryant HU.

Mol Pharmacol. 2005 Mar;67(3):744-8. Epub 2004 Nov 22.

PMID:
15557561
12.

Cloning and analysis of axolotl ISL2 and LHX2 LIM-homeodomain transcription factors.

Showalter AD, Yaden BC, Chernoff EA, Rhodes SJ.

Genesis. 2004 Mar;38(3):110-21.

PMID:
15048808
13.

Transcriptional control during mammalian anterior pituitary development.

Savage JJ, Yaden BC, Kiratipranon P, Rhodes SJ.

Gene. 2003 Nov 13;319:1-19. Review.

PMID:
14597167

Supplemental Content

Loading ...
Support Center